-
Signature
-
/s/ Joshua N. Silverman
-
Issuer symbol
-
PMCB
-
Transactions as of
-
05 Jan 2026
-
Net transactions value
-
+$80,476
-
Form type
-
4
-
Filing time
-
07 Jan 2026, 17:43:33 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Silverman Joshua |
CEO and President, Director |
C/O PHARMACYTE BIOTECH, INC., 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS |
/s/ Joshua N. Silverman |
07 Jan 2026 |
0001524858 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PMCB |
Common Stock |
Purchase |
$23,493 |
+30,000 |
+9.5% |
$0.7831 |
346,250 |
05 Jan 2026 |
Direct |
|
| transaction |
PMCB |
Common Stock |
Purchase |
$23,667 |
+30,000 |
+8.7% |
$0.7889 |
376,250 |
06 Jan 2026 |
Direct |
|
| transaction |
PMCB |
Common Stock |
Purchase |
$33,316 |
+40,000 |
+11% |
$0.8329 |
416,250 |
07 Jan 2026 |
Direct |
|
| holding |
PMCB |
Common Stock |
|
|
|
|
|
50,000 |
05 Jan 2026 |
JNS Holdings Group LLC |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Remarks:
Exhibit 24.1, Power of Attorney